Recent Finacing
Recent Raise
Hangzhou Just Biotherapeutics develops antibody and recombinant protein therapeutics and a biomanufacturing and process-development platform for oncology, rare genetic, and metabolic diseases, with R&D sites in Hangzhou and Boston.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
